PURPOSE: Neuroendovascular treatments are usually performed using a guiding catheter/sheath system larger than 5French (Fr). Hemorrhagic complications often occur at puncture sites following such procedures. In this study, safety and efficacy in neuroendovascular treatment of a newly developed 4.3Fr guiding sheath system that has the equivalent inner diameter of a 6Fr guiding catheter/sheath system were retrospectively evaluated. METHODS: From January 2004 to June 2007, 74 patients (33 men, 41 women; aged 39-88 years; mean 68.4) underwent neuroendovascular treatment using a 4.3Fr guiding sheath system. Diseases included cerebral aneurysms (n=48), acute occlusion of intracranial arteries (n=16), symptomatic vasospasm (n=8), and others (n=2). Success rate for the procedure, manual compression time at the puncture site, ambulation time, and periprocedural complications were analyzed by reviewing medical records of all 74 patients. RESULTS: The success rate of the procedure was 98.6%. After the procedure, manual compression time ranged from 7 to 35 minutes (mean 14.1), and time for bed rest from 3 to 14 hours (mean 11.0). A small subcutaneous hematoma at the puncture site was observed in 3 patients (4.1%). There were no other complications. CONCLUSION: The 4.3Fr guiding sheath system showed good maneuverability that was comparable to 5-6Fr guiding catheter/sheath systems and could reduce the risk of local hemorrhagic complications.
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